Sharmila Banerjee
Mumbai, MH, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Design and development of a semi-automated solid target assembly for the indigenous production of medical radioisotopes in the PETrace-800 cyclotron.
Journal: EJNMMI radiopharmacy and chemistry
Published: November 23, 2025
Reliable localization of insulinomas with [68Ga]Ga-NODAGA-Lys40-Exendin-4: a preliminary evaluation and clinical illustration.
Journal: EJNMMI research
Published: June 29, 2025
Convenient one-pot synthesis of 1-(4-(4-(2-[18F]fluoroethoxy)phenyl)piperazin-1-yl)ethanone ([18F]FEt-PPZ) for imaging tumors expressing sigma-1 receptors.
Journal: RSC advances
Published: April 29, 2025
Publisher Correction: On the automated radiosynthesis of pharmaceutical grade [68Ga]Ga-Pentixafor, its pre-clinical evaluation, clinical application and radiation dosimetry aspects.
Journal: Scientific reports
Published: April 24, 2025
On the automated radiosynthesis of pharmaceutical grade [68Ga]Ga-Pentixafor, its pre-clinical evaluation, clinical application and radiation dosimetry aspects.
Journal: Scientific reports
Published: August 06, 2024
Clinical Internal Dosimetry and Biodistribution of 177 Lu-DOTA-Trastuzumab in HER2-Positive Metastatic and Locally Advanced Breast Carcinoma.
Journal: Clinical nuclear medicine
Published: February 13, 2024
On the Optimization of the Protocol for Automated Radiosyntheses of [68Ga]Ga-Pentixafor, [68Ga]Ga-FAPI-4 and [68Ga]Ga-DOTATATE in a Modular-Lab Standard.
Journal: Asia Oceania journal of nuclear medicine & biology
Published: December 25, 2023
Clinical Dose Preparation of [177Lu]Lu-DOTA-Pertuzumab Using Medium Specific Activity [177Lu]LuCl3 for Radioimmunotherapy of Breast and Epithelial Ovarian Cancers, with HER2 Receptor Overexpression.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: May 16, 2022
Automated radiochemical synthesis of pharmaceutical grade [18 F]FLT using 3-N-Boc-5'-O-dimethoxytrityl-3'-O-nosyl-thymidine precursor and its Sep-Pak® purification employing selective elution from reversed phase.
Journal: Journal of labelled compounds & radiopharmaceuticals
Published: January 19, 2022
Estimation of Absorbed Doses of Indigenously Produced "Direct-route" Lutetium-177-[177Lu]Lu-DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [177Lu]Lu-DOTA-TATE and the Trend with Multiple Cycles.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: December 15, 2021
Prospective evaluation of organ-specific dose and lesional doses following therapeutic [177Lu]Lu-EDTMP administration in patients with multiple skeletal metastases and its correlation with clinical hematological toxicity.
Journal: Nuclear medicine communications
Published: September 16, 2021
Last Updated: 09/26/2026